Clinical outcomes of advanced non-small-cell lung cancer patients with <i>EGFR</i> mutation, <i>ALK</i> rearrangement and <i>EGFR</i>/<i>ALK</i> co-alterationsNa-Na Lou, Jin‐Ji Yang|Oncotarget|2016Cited by 39
Expert consensus on treatment for stage III non‐small cell lung cancerYi‐Long Wu, Yun Fan, Buhai Wang et al.|Medicine Advances|2023Cited by 18
Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancerShiling Zhang, Jin‐Ji Yang|Journal of Thoracic Disease|2023Cited by 9